Cluster randomized trial in smoking cessation with intensive advice in diabetic patients in primary care. ITADI Study

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Roig, Lydia ^a   Perez, Santiago ^a   Prieto, Gemma ^b   Martin, Carlos ^a   Advani, Mamta ^c   Armengol, Angelina ^a   Roura, Pilar ^a   Maria Manresa, Josep ^d   Briones, Elena ^e  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b Sanidad de Castilla y Léon ^*  (Spain)

^c Research and Devmt Sci Area   (Spain)

^d IDIAP Jordi Gol   (Spain)

^e USR Barcelona   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; INFORMATION PROCESSING; INTERVIEW; MALE; METHODOLOGY; MOTIVATION; MULTICENTER STUDY; PATIENT CARE; PATIENT SELECTION; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION;

ATTITUDE TO HEALTH; DATA COLLECTION; DIABETES MELLITUS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MOTIVATION; PATIENT CARE TEAM; PATIENT SELECTION; PRIMARY HEALTH CARE; RESEARCH DESIGN; SMOKING; SMOKING CESSATION;

EID: 77249131253     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-58     Document Type: Article

References (32)

1. Annual Smoking- Attributable Mortality, Years of Potential Life Lost, and Productivity Losses - United States, 1997-2001. Center for Disease Control and Prevention, MMWR Morb Mortal Wlly Rep 2005 54 625 628
2. Mortality in relation to smoking: 50 years' observations on male British doctors. R Doll R Peto J Boreham I Sutherland, BMJ 2004 328 1519 10.1136/bmj.38142.554479.AE 15213107
3. [Recent decrease in smoking-attributable mortality in Spain]. JR Banegas GL Diez EJ Gonzalez AF Villar F Rodriguez-Artalejo, Med Clin (Barc) 2005 124 769 771 10.1157/13075847 15927102
4. Smoking and diabetes. D Haire-Joshu RE Glasgow TL Tibbs, Diabetes Care 2004 27 Suppl 1 74 S75 14693932
5. Diabetic neuropathies: a statement by the American Diabetes Association. AJ Boulton AI Vinik JC Arezzo V Bril EL Feldman R Freeman, et al. Diabetes Care 2005 28 956 962 10.2337/diacare.28.4.956 15793206
6. Treating Tobacco Use and Dependence: 2008 Update. MC Fiore C Jaen T Baker, et al. Public Health Services Clinical Practice Guideline Rockville, MD: US Department of Health and Human Services Public Health Service 2008 2008 22-12-2009
7. Detecciá i tractament del consum del tabac. S Granollers, et al. Guies de prctica clínica, nm.14. Institut Catala de Salut Barcelona: Institut Catal de la Salut 2009 15-10-2009
8. Standards of Medical Care in Diabetes-2009. Diabetes Care 2009 32 13 S61 10.2337/dc09-S013 19118286
9. Applying the transtheoretical model to tobacco cessation and prevention: a review of literature. L Spencer F Pagell ME Hallion TB Adams, Am J Health Promot 2002 17 7 71 12271754
10. Systematic review of the effectiveness of stage based interventions to promote smoking cessation. RP Riemsma J Pattenden C Bridle AJ Sowden L Mather IS Watt, et al. BMJ 2003 326 1175 1177 10.1136/bmj.326.7400.1175 12775617
11. Smoking and diabetes: readiness for change and provider advice. L Ruggiero JS Rossi JO Prochaska RE Glasgow M de Groot JM Dryfoos, et al. Addict Behav 1999 24 573 578 10.1016/S0306-4603(98)00086-0 10466853
12. Comparison of questionnaire, breath carbon monoxide and urine cotinine in assessing the smoking habits of Type 2 diabetic patients. AA Ismail GV Gill K Lawton GM Houghton IA MacFarlane, Diabet Med 2000 17 119 123 10.1046/j.1464-5491.2000.00230.x 10746481
13. Effect of a general practicioners' advice again smoking. MA Russell C Wilson C Taylor CD Baker, British Medical Journal 1979 2 231 235 10.1136/bmj.2.6184.231 476401
14. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. T Lancaster L Stead C Silagy A Sowden, BMJ 2000 321 355 358 10.1136/bmj.321.7257.355 10926597
15. [Guidelines for a diagnostic and therapeutic approach to smoking addiction. A consensus report]. CA Jimenez Ruiz FM Barrueco RS Solano GM Torrecilla GF Dominguez JL Diaz-Maroto Munoz, et al. Arch Bronconeumol 2003 39 35 41 10.1157/13042417 12550018
16. Treating tobacco use and dependence. Clinical Practice Guideline. MC Fiore WC Bailey SJ Cohen, et al. Public Health Service US Department of Health and Human Services 2000 6-1-2000
17. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. DE Jorenby JT Hays NA Rigotti S Azoulay EJ Watsky KE Williams, et al. JAMA 2006 296 56 63 10.1001/jama.296.1.56 16820547
18. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. D Gonzales SI Rennard M Nides C Oncken S Azoulay CB Billing, et al. JAMA 2006 296 47 55 10.1001/jama.296.1.47 16820546
19. Smoking cessation services in primary care, pharmacies, local authorities and workplaces, particularly for manual working groups, pregnant women and hard to reach communities. United Kingdom: National Institute for Health and Clinical Excellence 2008
20. Effectiveness of a stepped primary care smoking cessation intervention (ISTAPS study): design of a cluster randomised trial. C Cabezas C Martin S Granollers C Morera JL Ballve E Zarza, et al. BMC Public Health 2009 9 48 19193233
21. Difficulties of smoking cessation in diabetic inpatients benefiting from a systematic consultation to help them to give up smoking. O Scemama E Hamo-Tchatchouang AL Le Faou JJ Altman, Diabetes Metab 2006 32 435 441 10.1016/S1262-3636(07)70301-4 17110898
22. Smoking cessation in patients with diabetes mellitus: results from a controlled study of an intervention programme in primary healthcare in Sweden. LG Persson A Hjalmarson, Scand J Prim Health Care 2006 24 75 80 10.1080/02813430500439395 16690554
23. Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings. N Canga IJ De E Vara MJ Duaso A Ferrer MA Martinez-Gonzalez, Diabetes Care 2000 23 1455 1460 10.2337/diacare.23.10.1455 11023136
24. Integrated tobacco cessation counseling in a diabetes self-management training program: a randomized trial of diabetes and reduction of tobacco. JM Hokanson RL Anderson DJ Hennrikus HA Lando DM Kendall, Diabetes Educ 2006 32 562 570 10.1177/0145721706289914 16873594
25. Guidelines for the Development of a National. Programme for Diabetes Mellitus. GE Reiber H King, World Health Organization/DBO/. DM/91.1. World Health Organization 1991
26. Recomendaciones sobre estilo de vida. R Cordoba R Ortega C Cabezas D Fores M Nebot T Robledo, Atencián Primaria 2001 28 27 34
27. New Zealand National Advisory Committee on Health and Disability. Guidelines for smoking cessation, 2002
28. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. G Adams MC Gulliford OC Ukoumunne S Eldridge S Chinn MJ Campbell, J Clin Epidemiol 2004 57 785 794 10.1016/j.jclinepi.2003.12. 013 15485730
29. Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART). DR Parker E Evangelou CB Eaton, Contemp Clin Trials 2005 26 260 267 10.1016/j.cct.2005.01. 002 15837446
30. Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. OC Ukoumunne MC Gulliford S Chinn JA Sterne PG Burney, Health Technol Assess 1999 3 ii 92 10982317
31. [The CONSORT statement for cluster randomised trials]. MK Campbell DR Elbourne DG Altman, Med Clin (Barc) 2005 125 Suppl 1 28 31 10.1016/S0025- 7753(05)72206-5 16464424
32. Cámo podríamos mejorar los resultados de nuestros consejos de salud? J Cebra JM Bosch JA Prados, Atencián Primaria 2000 7 320 322